AC
RVMD icon

AXQ Capital’s Revolution Medicines RVMD Stock Holding History

AXQ Capital’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-22,946
Closed -$2.23M – 1296
2026
Q1 		$2.23M Buy
+22,946
New +$2.32M 0.29% 90
2025
Q3 		– Sell
-7,658
Closed -$282K – 791
2025
Q2 		$282K Buy
+7,658
New +$294K 0.09% 380
2024
Q2 		– Sell
-9,200
Closed -$297K – 692
2024
Q1 		$297K Buy
+9,200
New +$273K 0.07% 433

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

AXQ Capital's RVMD Position: Q2 2026 in Review

AXQ Capital sold out of Revolution Medicines (RVMD) in Q2 2026, closing a stake of 22,946 shares — an estimated $2.23M sold.

AXQ Capital first reported a position in RVMD in Q1 2024 and held it in 3 quarters. The position peaked at $2.23M in Q1 2026. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • AXQ Capital reported no remaining Revolution Medicines position as of Q2 2026 after selling out during the quarter.
  • AXQ Capital sold 22,946 Revolution Medicines shares in Q2 2026, an estimated $2.23M.
  • AXQ Capital first reported a position in Revolution Medicines in Q1 2024 and held it in 3 quarters.
  • AXQ Capital's Revolution Medicines position peaked at $2.23M in Q1 2026.
  • 691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.